性做久久久久久坡多野结衣-性做久久久久久久久浪潮-性欲影院-性影院-国产精品线路一线路二-国产精品兄妹在线观看麻豆

產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊

當前位置:
美國布魯克海文儀器公司>技術(shù)文章>Nanobrook Omni測量應(yīng)用案例-15

技術(shù)文章

Nanobrook Omni測量應(yīng)用案例-15

閱讀:237          發(fā)布時間:2018-6-19

文獻名: Lipidic Nanoparticles Comprising Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe Disease

 

作者Jennifer L.Schneider, Robert K.Dingman, Sathy V.Balu-Iyer 

Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14214

 

摘要:Enzyme replacement therapy with recombinant human acid α-glucosidase (rhGAA) is complicated by the formation of anti-rhGAA antibodies, a short circulating half-life, instability in the plasma, and limited uptake into target tissue. Previously, we have demonstrated that phosphatidylinositol (PI) containing liposomes can reduce the immunogenicity and extend plasma survival of factor VIII (FVIII) in a mouse model of hemophilia A. In this article, we investigate the ability of PI liposomes to be used as a delivery vehicle to overcome the issues that complicate therapy with rhGAA. In a murine model of Pompe disease, administration of PI-rhGAA mitigated the immunogenicity of rhGAA, resulting in a significantly lower formation of anti-rhGAA antibodies. PI-rhGAA also showed minimal improvements to the pharmacokinetic parameters and efficacy measures compared to free rhGAA. Overall, these data suggest that PI-rhGAA may have the potential to be a useful therapeutic option for improving the treatment of Pompe disease.

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復(fù)您~

對比框

產(chǎn)品對比 產(chǎn)品對比 聯(lián)系電話 二維碼 意見反饋 在線交流

掃一掃訪問手機商鋪
010-62081908
在線留言
主站蜘蛛池模板: 富阳市| 会同县| 鄱阳县| 湖北省| 浏阳市| 龙川县| 平乐县| 宁夏| 聂拉木县| 舞钢市| 西丰县| 奉贤区| 双桥区| 海门市| 什邡市| 慈溪市| 通山县| 安仁县| 绥阳县| 盈江县| 剑阁县| 尉犁县| 沅陵县| 海淀区| 南涧| 宣恩县| 宜川县| 伊金霍洛旗| 浠水县| 青铜峡市| 兴宁市| 福泉市| 灵石县| 定南县| 陆良县| 大安市| 万宁市| 隆回县| 屏东县| 泰安市| 嵊州市|